Breakthrough Business Models: Drug Development for Rare and Neglected Diseases and Individualized Therapies: Workshop Summary
Read a fragment
Instant download
after payment (24/7)
Wide range of formats
(for all gadgets)
Full book
(including for Apple and Android)
The process for developing new drug and biologic products is extraordinarily expensive and time-consuming. Although large pharmaceutical companies may be able to afford the cost of development because they can expect a large return on investment, organizations developing drugs to treat rare and neglected diseases are unable to rely on such returns. On June 23, 2008, the Institute of Medicine's Forum on Drug Discovery, Development, and Translation held a public workshop, "Breakthrough Business Models: Drug Development for Rare and Neglected Diseases and Individualized Therapies," which sought to explore new and innovative strategies for developing drugs for rare and neglected diseases.
LF/294902/R
Data sheet
- Name of the Author
- Development
Institute of Medicine
Robert Giffin
Sally Robinson
Theresa Wizeman
and Translation Forum on Drug Discovery - Language
- English
- ISBN
- 9780309120883
- Release date
- 2009
